Shari Margolese: Where Power Lives

IAC: Botswana, Don’t You Wanna Get Tested?

IAC: Diary of a Doc (The DART Debate)

IAC: Fifty Ways to Protect Your Lover

IAC: Markowitz on MK-0518

Violence and the Virus: IAC Women Say Hands Off

IAC: He Loves Me, He Loves Me Not

IAC: Kotler Responds to Critics of FRAM

IAC: Fauci Gets Grilled

IAC: Activist Gonsalves Slams Gates & Clinton

IAC: Markowitz on the Supervirus Case

IAC: Diary of a Doc (Part Two)

Oh Canada! Making Trouble at IAC

IAC: Diary of a Doc

IAC: Highlights From Toronto, Day One

IAC: African Americans Take a Seat at the Table

IAC: Is Kaletra Monotherapy Possible?

IAC: Sustiva vs. Kaletra? We Have a Likely Winner

IAC: Lead Researcher Discusses KLEAN

IAC: Lexiva Measures Up to Kaletra

IAC: Maraviroc Less Effective but Safe for Some

IAC: Vicriviroc Shows Promise

IAC: Data, Access for Integrase Inhibitor

IAC: Encouraging TNX-355 Data

IAC: Growth Hormone for Lipo

IAC: Tibotec VP Discusses Latest On Prezista

IAC: Nutritional Boost CD4 Counts

IAC: Meds Improve Growth and Body Composition

IAC: AIDS Focus Shifts to Prevention (Reuters Health)

IAC: Challenges of Reaching Countries in Need

IAC: Encouraging Data on Etravirine (TMC-125)

IAC: 48-Week Prezista POWER Results Presented

IAC: Serostim As Immune-Based Therapy?

IAC: Four Drugs Vs. Three